Galsky MD - Search Results

1

A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.

Meeks JJ, Bellmunt J, Bochner BH, Clarke NW, Daneshmand S, Galsky MD, Hahn NM, Lerner SP, Mason M, Powles T, Sternberg CN, Sonpavde G. Meeks JJ, et al. Among authors: galsky md. Eur Urol. 2012 Sep;62(3):523-33. doi: 10.1016/j.eururo.2012.05.048. Epub 2012 Jun 1. Eur Urol. 2012. PMID: 22677572 Review.

2

The role of taxanes in the management of bladder cancer.

Galsky MD. Galsky MD. Oncologist. 2005 Nov-Dec;10(10):792-8. doi: 10.1634/theoncologist.10-10-792. Oncologist. 2005. PMID: 16314289 Free article. Review.

3

Violaceous exanthem as a manifestation of metastatic prostate cancer in skin.

Slovin SF, Galsky MD, Busam K. Slovin SF, et al. Among authors: galsky md. Urology. 2006 Feb;67(2):420. doi: 10.1016/j.urology.2005.08.033. Urology. 2006. PMID: 16461102 No abstract available.

4

Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder.

Dash A, Galsky MD, Vickers AJ, Serio AM, Koppie TM, Dalbagni G, Bochner BH. Dash A, et al. Among authors: galsky md. Cancer. 2006 Aug 1;107(3):506-13. doi: 10.1002/cncr.22031. Cancer. 2006. PMID: 16773629 Free article.

5

Problems with the randomized discontinuation design.

Sonpavde G, Hutson TE, Galsky MD, Berry WR. Sonpavde G, et al. Among authors: galsky md. J Clin Oncol. 2006 Oct 1;24(28):4669-70; author reply 4670-1. doi: 10.1200/JCO.2006.08.1026. J Clin Oncol. 2006. PMID: 17008711 No abstract available.

6

Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function.

Galsky MD, Iasonos A, Mironov S, Scattergood J, Boyle MG, Bajorin DF. Galsky MD, et al. Cancer. 2007 Feb 1;109(3):549-55. doi: 10.1002/cncr.22454. Cancer. 2007. PMID: 17200962 Free article. Clinical Trial.

7

Targeting growth factor and antiangiogenic pathways in clear-cell renal cell carcinoma: rationale and ongoing trials.

Hutson TE, Sonpavde G, Galsky MD. Hutson TE, et al. Among authors: galsky md. Clin Genitourin Cancer. 2006 Dec;5 Suppl 1:S31-9. doi: 10.3816/cgc.2006.s.005. Clin Genitourin Cancer. 2006. PMID: 17239282 Review.

8

Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.

Galsky MD, Iasonos A, Mironov S, Scattergood J, Donat SM, Bochner BH, Herr HW, Russo P, Boyle MG, Bajorin DF. Galsky MD, et al. Urology. 2007 Feb;69(2):255-9. doi: 10.1016/j.urology.2006.10.029. Urology. 2007. PMID: 17320659 Clinical Trial.

9

Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.

Sonpavde G, Chi KN, Powles T, Sweeney CJ, Hahn N, Hutson TE, Galsky MD, Berry WR, Kadmon D. Sonpavde G, et al. Among authors: galsky md. Cancer. 2007 Dec 15;110(12):2628-39. doi: 10.1002/cncr.23085. Cancer. 2007. PMID: 17941029 Free article. Review.

10

Germ-cell tumors.

Kondagunta V, Galsky MD, Sonpavde G. Kondagunta V, et al. Among authors: galsky md. N Engl J Med. 2007 Oct 25;357(17):1773; author reply 1773-4. N Engl J Med. 2007. PMID: 17969229 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

425 results

Search Page

Filters